The FDA has approved AstraZeneca’s blockbuster drug Nexium for children ages 1–11 for the short-term treatment of gastroesophageal reflux disease. ...
By Vikas Dandekar, CNBC-TV18 Sources close to CNBC-TV18 have reported that Ranbaxy is weighing its options to launch its generic Nexium, at risk, ...
Nexium sales fell 2 percent last year to $5.22 billion, and the company forecast the drug's revenue probably will decline this year. ...
By Anna Boyd The US Food and Drug Administration on Thursday approved esomeprazole magnesium, also known as Nexium for short treatment of gastroesophageal ...
Zurich, Switzerland (AHN) - Nexium has been approved for short-term use by the Food and Drug Administration for children aged 1 to 11 who are suffering from ...
The FDA approved esomeprazole (Nexium) to help short term gastroesophagel reflux disease (GERD) in children between the ages of 1 and 11. ...
By Veronica Dagher The Food and Drug Administration approved gastroesophageal reflux disease drug Nexium for short-term use in children ages 1 to 11 years. ...
SAN FRANCISCO (Thomson Financial) - AstraZeneca on Thursday said the Food and Drug Administration has approved the use of Nexium in children ages one to 11 ...
The Food and Drug Administration on Thursday approved AstraZeneca's Nexium to treat chronic heartburn in children. The agency cleared two formulations of ...
WASHINGTON (AP) — The Food and Drug Administration has approved use of the drug Nexium in children aged 1 to 11 who have acid reflux disease. ...